RNLX
FY2027 EPS Estimate
$0.48
FY2027E EPS$0.48

Analyst Sentiment

Wall St. Consensus
Buy
4 analysts·Low coverage
75
Score
4 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
4100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.00
+865.7%
Consensus
$2.00
+865.7%
Bull
$2.00
+865.7%
12-Month Target Range4 analysts
$2.00$2.00$2.00
Current $0.21Consensus
Current Price
$0.21
Upside to Consensus
$1.79

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+84.81%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2027E
Revenue Avg$114M
Low$114M
High$114M
EBITDA Avg$42M
Low$42M
High$42M
EBIT Avg$33M
Low$33M
High$33M
Net Income Avg$26M
Low$26M
High$26M
EPS Avg$0.48
Low$0.48
High$0.48
Analysts (Rev / EPS)1 / 1

Earnings Surprises

Recent Analyst Actions

May 16, 2024BTIG
Renalytix AI Plc. (RNLX) PT Lowered to $2 at BTIG
Target:$2.00
+252.7%from $0.57
Jul 1, 2022BTIG
Renalytix price target lowered to $5 from $15 at BTIG
Target:$5.00
+104.1%from $2.45
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.